LMAT - Should Investors Consider This Expanding Healthcare Business After Its Massive Dividend Hike?
When a company initiates a huge dividend increase, its investors typically receive the news warmly. But it's always important to look deeper -- especially with a large payout rise.
Recently, LeMaitre Vascular (NASDAQ: LMAT) announced it was increasing its quarterly dividend from $0.095 per share to $0.11. That marks a 15.8% raise to a yield of 0.7%, still notably less than the S&P 500 's average of about 1.3%.
While this could indicate that management and the board of directors have confidence in its business prospects, such a payout increase could also have overextended the company's dividend obligation. Does LeMaitre's dividend remain sustainable going forward -- and is it a good buy for long-term appreciation and/or income?
For further details see:
Should Investors Consider This Expanding Healthcare Business After Its Massive Dividend Hike?